Diabetes decisions — 2025

The Board denied service connection for bilateral hearing loss and a compensable rating for Tietze's disease. The claims for low back condition, heart condition, and diabetes mellitus were remanded for further evaluation.

The appeal for service connection of type II diabetes mellitus, including as secondary to hypothyroidism, is remanded. The Board needs more medical evidence to determine if the diabetes is related to military service.

The Board remanded all issues to further develop whether the Veteran was exposed to PFAS during his service, which could influence his claims for service connection.

The Veteran's service-connected disabilities are severe enough to prevent him from securing or following substantially gainful employment, so a total disability rating based on individual unemployability (TDIU) is granted.

The Board denied service connection for PTSD, MDD, anxiety, and diabetes mellitus due to lack of evidence supporting the claimed in-service stressors and absence of a diagnosis for diabetes.

The Board remanded the veteran's claim for service connection of diabetes mellitus, Type II, to include as secondary to major depressive disorder. The Board will consider new evidence if submitted.

The appeal for service connection of diabetes mellitus is remanded. The Board needs more information about the veteran's exposure to herbicides.

The Board denied service connection for diabetes mellitus type II and unspecified anxiety disorder due to insufficient evidence linking these conditions to the veteran's military service.

The veteran's claim for service connection for chronic kidney disease was granted with an effective date of April 11, 2023. All other claims for increased disability ratings were denied due to the veteran's failure to attend scheduled VA examinations.

The veteran's claim for service connection for diabetes mellitus, type II is granted based on presumed exposure to herbicide agents during his service in Korea.

The veteran withdrew their appeals for higher ratings and service connection, so the Board dismissed all issues.

The Board remanded the veteran's claims for service connection for diabetes and peripheral neuropathy due to tactical herbicide exposure. The veteran will be provided notice of his right to a hearing, and the claims will be readjudicated.

The Board denied earlier effective dates for service connection of hypertension and PTSD. It dismissed claims for earlier effective dates for ratings of hemorrhoids, lumbosacral strain, hearing loss, and sciatic radiculopathy. The Board also denied higher ratings for these conditions and remanded the claims for service connection for diabetes and sleep apnea.

The Board remanded the veteran's claims for service connection for type II diabetes mellitus and peripheral neuropathy due to new evidence. The VA will re-evaluate these claims considering all submitted evidence.

The veteran's claim for service connection for hyperlipidemia was denied. All other claims were remanded for further development.

The veteran's service connection for hypertension, diabetes mellitus type II, and several types of peripheral neuropathy was granted. Service connection for kidney disease, anemia, and monoclonal gammopathy was also granted. However, the issues regarding congestive heart failure and body fluid retention were remanded.

The Veteran's claim for service connection for obstructive sleep apnea (OSA) on a secondary basis to his service-connected diabetes mellitus type 2 and bilateral peripheral neuropathy has been granted.

The Board remanded the claim for service connection of obstructive sleep apnea (OSA) because the VA did not provide an adequate medical opinion regarding the cause of OSA. The Veteran will receive a new examination.

The Board dismissed the claim for neuro-behavioral effects due to procedural defects. All other issues related to service connection and rating for various conditions were remanded for further adjudication.

The veteran's service connection for diabetes mellitus type II and related conditions was granted with an effective date of September 23, 2013. Service connection for prostate cancer and hypertension was also granted. However, higher disability ratings were denied, and some issues were remanded.